When people are asked to choose who gets a life-saving vaccine, their answers don’t match the logic that drives most healthcare funding decisions.
Articles on Quality-adjusted life years (QALY)
Displaying all articles
A new study has attempted to quantify the pandemic’s effects on global health by surveying people across 13 countries.
With the impact and cost of long COVID becoming ever more apparent, ongoing pandemic responses will need to be about protecting quality of life as much as saving lives.
Specialty prescription drugs are responsible for countless medical miracles, but their high price tag is the main reason health care costs are out of control.
Most of us would agree that cancer drugs should be listed on the PBS, no matter how dear. But our health system can’t afford all of them. How then are decisions about which drugs to subsidise made?
Top contributors
-
Professor of Health Economics, University of Oxford
-
Associate Professor in Health Economics, Flinders University
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Research Fellow, Flinders University
-
Adjunct Associate Professor, Centre for Applied Energy Economics and Policy Research, Griffith University
-
Professor of Health Economics, Flinders University
-
Researcher in Health Economics, University of Oxford
-
Senior Researcher, Health Economics, University of Oxford
-
PhD Candidate, Health Economics, Erasmus University Rotterdam
-
Associate Professor, Health Economics, University of Oxford